Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | CA12 | O43570 | 7/20 | 0.59 |
| ▸ | CA2 | P00918 | 6/20 | 0.59 |
| ▸ | FBP1 | P09467 | 6/20 | 0.57 |
| ▸ | ELANE | P08246 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23699755 | 0.85 | CYP2D6 (0.68) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL7781184 | 0.84 | CYP2D6 (0.66) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL11287638 | 0.82 | CYP2D6 (0.64) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL10656285 | 0.81 | FBP1 (0.64) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL19848646 | 0.81 | CYP2D6 (0.59) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL9678250 | 0.81 | CYP2D6 (0.59) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL11443197 | 0.81 | CYP2D6 (0.59) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL9967796 | 0.81 | CYP2D6 (0.59) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL12606536 | 0.81 | KDM4E (0.52) | CYP2D6TSHRCA9CA12CA2 | |
| SCHEMBL12646984 | 0.81 | FBP1 (0.62) | CYP2D6TSHRCA9CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009016648-A2 | PROCESS FOR THE PREPARATION OF ROCURONIUM BROMIDE AND INTERMEDIATE THEREOF | GLAND PHARMA LIMITED (IN) | 2009-02-05 | — | — | WO | claimed |
| JP-61158926-A | — | — | None | — | — | JP | disclosed |
| US-11752242-B2 | Medical devices, systems, and methods utilizing antithrombin-heparin composition | ATH THERAPEUTICS INC. (US) | 2023-09-12 | — | — | US | disclosed |
| CN-114207122-A | Mutant PGLB oligosaccharyl transferases | 葛兰素史克生物有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20190030066-A1 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | ATTWILL Medical Solutions, Inc. (CA) | 2019-01-31 | — | — | US | disclosed |
| US-20180177924-A1 | Medical Devices, Systems, and Methods Utilizing Antithrombin-Heparin Composition | ATTWILL Medical Solution Inc. (CA) | 2018-06-28 | — | — | US | disclosed |
| US-20170020911-A1 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | ATTWILL MEDICAL SOLUTIONS INC. (CA) | 2017-01-26 | — | — | US | disclosed |
| WO-2016201202-A1 | MEDICAL DEVICES, SYSTEMS, AND METHODS UTILIZING ANTITHROMBIN-HEPARIN COMPOSITIONS | ATTWILL MEDICAL SOLUTIONS INC. (CA) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016168710-A1 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | ATTWILL MEDICAL SOLUTIONS INC. (CA) | 2016-10-20 | — | — | WO | disclosed |
| CN-103328400-B | Glass fiber bundling agent and glass fiber reinforced crystalline resin composition | ADEKA CORP. (JP) | 2015-12-02 | — | — | CN | disclosed |
| US-6562781-B1 | Covalent conjugate composition comprising glycosaminoglycans linked by covalent linkages to a species comprising at least one primary amino group | HAMILTON CIVIC HOSPITALS RESEARCH DEVELOPMENT INC. (CA) | 2003-05-13 | — | — | US | disclosed |
| US-6491965-B1 | COVALENT LINKAGES COMPRISING AN ALPHA CARBONYL AMINE FORMED BY A AMADORI REARRANGEMENT OF AN IMINE RESULTING FROM REACTION BETWEEN SAID AMINO GROUP OF ANTITHROMBIN AND TERMINAL ALDOSE RESIDUE OF HEPARIN | HAMILTON CIVIC HOSPITALS RESEARCH DEVELOPMENT, INC. (CA) | 2002-12-10 | — | — | US | disclosed |
| US-5985815-A | Bleach activators | WARWICK INTERNATIONAL GROUP LIMITED (GB) | 1999-11-16 | — | — | US | disclosed |
| EP-0863768-A2 | GLYCOSAMINOGLYCAN-ANTITHROMBIN III/HEPARIN COFACTOR II CONJUGATES | HAMILTON CIVIC HOSPITALS RESEARCH DEVELOPMENT, INC. (CA) | 1998-09-16 | — | — | EP | disclosed |
| EP-0730632-B1 | BLEACH ACTIVATORS | WARWICK INT GROUP (GB) | 1998-03-18 | — | — | EP | disclosed |
| WO-1997019701-A2 | GLYCOSAMINOGLYCAN-ANTITHROMBIN III/HEPARIN COFACTOR II CONJUGATES | HAMILTON CIVIC HOSPITALS RESEARCH DEVELOPMENT, INC. (CA) | 1997-06-05 | — | — | WO | disclosed |
| EP-0730632-A1 | BLEACH ACTIVATORS | Warwick International Group Limited (GB) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014760-A1 | BLEACH ACTIVATORS | WARWICK INTERNATIONAL GROUP LIMITED (GB) | 1995-06-01 | — | — | WO | disclosed |
| JP-S61158926-A | CARCINOSTATIC AGENT CONTAINING POLYSACCHARIDE | SEIKO EPSON CORP | 1986-07-18 | — | — | JP | disclosed |
| US-3990983-A | CHLORINATED TRISODIUM PHOSPHATE, TRISODIUM CARBOXYMETHYLOXYSUCCINATE, SODIUM SULFATE, SODIUM SILICATE | LEVER BROTHERS COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11752242-B2 | Medical devices, systems, and methods utilizing antithrombin-heparin composition | SERPINC1, HPSE, PLAT | CYP2D6 1611/4885TSHR 357/4885CA9 801/4885 |
| US-20190030066-A1 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | SERPINC1, HPSE, SERPINA3 | CYP2D6 3679/4885TSHR 686/4885CA9 934/4885 |
| US-20170020911-A1 | ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS | SERPINC1, HPSE, SERPINA3 | CYP2D6 3679/4885TSHR 686/4885CA9 934/4885 |
| US-20180177924-A1 | Medical Devices, Systems, and Methods Utilizing Antithrombin-Heparin Composition | SERPINC1, HPSE, PLAT | CYP2D6 1611/4885TSHR 357/4885CA9 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.